|
|
 |
|
CDC suspends tuberculosis-HIV study Los Angeles Times The Centers for Disease Control and Prevention has suspended a drug trial for patients who have both tuberculosis and advanced HIV after five patients developed resistance to the drug. The study gave 159 patients twice-weekly doses of rifabutin, a TB drug that is considered safe to use in combination with protease inhibitors, which fight AIDS.
—Posted: March 15, 2002
More news headlines: This week | Last week | Search archive
|
|
|
